162 related articles for article (PubMed ID: 3465267)
1. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
Schwartz BS; Williams EC; Conlan MG; Mosher DF
Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
[TBL] [Abstract][Full Text] [Related]
2. Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.
Wassenaar T; Black J; Kahl B; Schwartz B; Longo W; Mosher D; Williams E
Hematol Oncol; 2008 Dec; 26(4):241-6. PubMed ID: 18613223
[TBL] [Abstract][Full Text] [Related]
3. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Williams EC
Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
[TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
Meyer K; Williams EC
Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
[TBL] [Abstract][Full Text] [Related]
5. epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.
Keane TJ; Gorman AM; O'Connell LG; Fennelly JJ
Acta Haematol; 1976; 56(4):202-4. PubMed ID: 826076
[TBL] [Abstract][Full Text] [Related]
6. Epsilon-aminocaproic acid (EACA).
Griffin JD; Ellman L
Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
Neidhart JA; Roach RW
Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
[TBL] [Abstract][Full Text] [Related]
8. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
[TBL] [Abstract][Full Text] [Related]
9. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
[TBL] [Abstract][Full Text] [Related]
10. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
Kettle P; Mayne EE
J Clin Pathol; 1985 Apr; 38(4):428-9. PubMed ID: 3988955
[TBL] [Abstract][Full Text] [Related]
11. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
[TBL] [Abstract][Full Text] [Related]
12. Thromboelastographic evidence of inhibition of fibrinolysis after ε-aminocaproic acid administration in a dog with suspected acute traumatic coagulopathy.
Yoo SH; Venn E; Sullivan LA; Olver CS
J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):737-42. PubMed ID: 26990227
[TBL] [Abstract][Full Text] [Related]
13. The modification of experimental allergic encephalomyelitis with epsilon aminocaproic acid.
Sibley WA; Kiernat J; Laguna JF
Neurology; 1978 Sep; 28(9 Pt 2):102-5. PubMed ID: 568743
[TBL] [Abstract][Full Text] [Related]
14. Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract.
Stefanini M; English HA; Taylor AE
J Urol; 1990 Mar; 143(3):559-61. PubMed ID: 2304169
[TBL] [Abstract][Full Text] [Related]
15. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
[TBL] [Abstract][Full Text] [Related]
16. Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency.
Okajima K; Kohno I; Soe G; Okabe H; Takatsuki K; Binder BR
Am J Hematol; 1994 Jan; 45(1):16-24. PubMed ID: 8250008
[TBL] [Abstract][Full Text] [Related]
17. The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate.
Lambert CJ; Marengo-Rowe AJ; Leveson JE; Green RH; Thiele JP; Geisler GF; Adam M; Mitchel BF
Ann Thorac Surg; 1979 Nov; 28(5):440-4. PubMed ID: 496496
[TBL] [Abstract][Full Text] [Related]
18. Use of epsilon aminocaproic acid in protracted bleeding from polycystic kidneys: a case report.
Rao KV
J Urol; 1986 Oct; 136(4):887-8. PubMed ID: 3761453
[TBL] [Abstract][Full Text] [Related]
19. Epsilon aminocaproic acid and the control of post-prostatectomy bleeding: a prospective double-blind study.
Smith RB; Riach P; Kaufman JJ
J Urol; 1984 Jun; 131(6):1093-5. PubMed ID: 6539381
[TBL] [Abstract][Full Text] [Related]
20. Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.
Takeda Y; Parkhill TR; Nakabayashi M
J Clin Invest; 1972 Oct; 51(10):2678-85. PubMed ID: 4262519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
